0703-5075 : Dacarbazine 200 mg/20ml Intravenous Injection
NDC: | 0703-5075 |
Labeler: | Teva Parenteral Medicines, Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Dacarbazine |
Dosage Form: | Intravenous Injection |
Application #: | ANDA075259 |
Rev. Date: |
NDC Package Codes:
- 0703-5075-01: 1 VIAL IN 1 CARTON (0703‑5075‑01) > 20 ML IN 1 VIAL
- 0703-5075-03: 10 VIAL, SINGLE‑USE IN 1 TRAY (0703‑5075‑03) > 20 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Dacarbazine
Dosage Strength:
- 200 mg/20mL
Pharmaceutical Classes:
- Alkylating Activity [MoA]
- Alkylating Drug [EPC]
Related Products:
Based on records with the same trade name.- 0143-9245 Dacarbazine 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
- 61703-327 Dacarbazine 200 mg/1 Intravenous Injection, Powder, for Solution by Hospira Worldwide, Inc.
- 63323-127 Dacarbazine 10 mg/ml Intravenous Injection, Powder, for Solution by App Pharmaceuticals, LLC
- 63323-128 Dacarbazine 10 mg/ml Intravenous Injection, Powder, for Solution by App Pharmaceuticals, LLC
- 71288-174 Dacarbazine 200 mg/20ml Intravenous Injection, Powder, for Solution by Meitheal Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0703-5054Next: 0703-5079 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.